Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer

Table 1 Clinical and pathological characteristics of patients with breast cancer in The Cancer Genome Atlas cohort

Variables	n	%
Age, yr
< 60	570	53.17
≥ 60	571	46.74
NA	1	0.09
Pathologic-T
T1	274	25.56
T2	621	57.93
T3	133	12.41
T4	40	3.73
TX	4	0.37
Pathologic-N
N0	502	46.83
N1	355	33.12
N2	118	11.01
N3	76	7.08
NA	21	1.96
Pathologic-M
M0	896	83.58
M1	22	2.05
NA	154	14.37
Stage
Stage I	176	16.41
Stage II	608	56.72
Stage III	246	22.95
Stage IV	20	1.87
NA	22	2.05
PAM50
Basal	136	12.69
Luminal-A	413	38.53
Luminal-B	185	17.25
Her2	66	6.16
Normal	22	2.05
NA	250	23.32